| Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery AI Gomez, MF Acosta, P Muralidharan, JXJ Yuan, SM Black, D Hayes Jr, ... Pulmonary pharmacology & therapeutics 64, 101975, 2020 | 32 | 2020 |
| In vitro pulmonary cell culture in pharmaceutical inhalation aerosol delivery: 2-D, 3-D, and in situ bioimpactor models M F Acosta, P Muralidharan, S A Meenach, D Hayes, S M-Black, ... Current pharmaceutical design 22 (17), 2522-2531, 2016 | 23 | 2016 |
| Inhalable nanoparticles/microparticles of an AMPK and Nrf2 activator for targeted pulmonary drug delivery as dry powder inhalers MF Acosta, MD Abrahamson, D Encinas-Basurto, JR Fineman, SM Black, ... The AAPS Journal 23, 1-14, 2021 | 19 | 2021 |
| Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried … W Alabsi, MF Acosta, FA Al-Obeidi, M Hay, R Polt, HM Mansour Pharmaceutics 13 (8), 1278, 2021 | 13 | 2021 |
| Design and comprehensive characterization of tetramethylpyrazine (TMP) for targeted lung delivery as inhalation aerosols in pulmonary hypertension (PH): In vitro human lung … P Muralidharan, MF Acosta, AI Gomez, C Grijalva, H Tang, JXJ Yuan, ... Antioxidants 10 (3), 427, 2021 | 11 | 2021 |
| Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: Design … MF Acosta, P Muralidharan, CL Grijalva, MD Abrahamson, D Hayes Jr, ... Therapeutic Advances in Respiratory Disease 15, 1753466621998245, 2021 | 8 | 2021 |
| Therapeutics in pulmonary hypertension MF Acosta, D Hayes, JR Fineman, JXJ Yuan, SM Black, HM Mansour Inhalation Aerosols, 313-322, 2019 | 6 | 2019 |
| Comparison of L-Carnitine and L-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in … MF Acosta, P Muralidhran, MD Abrahamson, CL Grijalva, M Carver, ... Pulmonary pharmacology & therapeutics 65, 101998, 2020 | 5 | 2020 |
| Solid-state physicochemical characterization and microscopy of particles in dry powder inhalers P Muralidharan, MF Acosta, DJ Hayes, SM Black, HM Mansour Inhalation 10 (2), 20-26, 2016 | 5 | 2016 |
| Abstracts: International Society for Aerosols in Medicine eV 21st ISAM Congress Santa Fe, NM June 3–7, 2017 YM Madney, M Fathy, AA Elberry J Aerosol Med Pulm Drug Delivery 30 (3), A-1-A-38, 2017 | 3 | 2017 |
| Compositions and methods for delivering pharmaceutical agents HM Mansour, S Black, M Acosta US Patent 11,904,054, 2024 | | 2024 |
| Fibrin-targeted phase shift microbubbles for the treatment of microvascular obstruction SA Mohammed, MW Amjad, MF Acosta, X Chen, L Lavery, D Hanrahan, ... Nanotheranostics 8 (1), 33, 2024 | | 2024 |
| The obesity paradox revisited: the body composition of myocardial infarction patients Y Croissant, D Costa, K Tapia, MB Barbosa, MF Acosta, M Muzzio, ... European Heart Journal: Acute Cardiovascular Care 12 (Supplement_1), zuad036 …, 2023 | | 2023 |
| Total body water and acute kidney injury in myocardial infarction K Tapia, B Barbosa, Y Croissant, D Costa, MF Acosta, V Gregorietti, ... European Heart Journal: Acute Cardiovascular Care 12 (Supplement_1), zuad036 …, 2023 | | 2023 |
| Sonoreperfusion with fibrin-targeted phase shift microbubbles for the treatment of microvascular obstruction SA Mohammed, MW Amjad, X Chen, MF Acosta, D Hanrahan, EJ Meuillet, ... The Journal of the Acoustical Society of America 153 (3_supplement), A141-A141, 2023 | | 2023 |
| Alkylated nucleosides, and compositions and methods thereof for nucleic acid delivery EC Unger, EJ Meuillet, MF Acosta, D Hanrahan US Patent App. 17/790,697, 2023 | | 2023 |
| Fibrin-Targeted Phase Shift Microbubbles Outperform Fibrin-Targeted Microbubbles for the Treatment of Microvascular Obstruction SA Mohammed, MW Amjad, XX Chen, MF Acosta, D Hanrahan, E Unger, ... Circulation 146 (Suppl_1), A15543-A15543, 2022 | | 2022 |
| Compositions and methods of detecting and treating thrombosis and vascular plaques EC Unger, EJ Meuillet, I Daryaei, MF Acosta US Patent App. 17/616,166, 2022 | | 2022 |
| Patient characteristics and periprocedural outcomes of percutaneous coronary intervention of the left main coronary artery D Costa, B Barbosa, K Tapia, M Matsudo, A Dadlicandro, MF Acosta, ... European Heart Journal: Acute Cardiovascular Care 11 (Supplement_1), zuac041 …, 2022 | | 2022 |
| Outcomes in patients with acute heart failure treated with levosimendan: the impact of right ventricular function D Costa, K Tapia, B Barbosa, MF Acosta, JP Cattaneo, E Catena, ... European Heart Journal: Acute Cardiovascular Care 11 (Supplement_1), zuac041 …, 2022 | | 2022 |
